News and media

Australian Health Protection Principal Committee (AHPPC) statement on the public health implications of the Omicron variant and response options.

A new Medical Research Future Fund (MRFF) grant opportunity will support Australian medical research and innovation projects to conduct trials of mRNA-based vaccines and therapeutics.

To continue support for Australian health and medical research, the Australian Government is making available $276.4 million through 12 research grant opportunities. Funding is from the Medical Research Future Fund (MRFF).

COVID-19 vaccination information kiosks are now open in shopping centres and events in Queensland, South Australia, Victoria, and Western Australia to help you book a vaccination appointment.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 15 December 2021.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) about the COVID-19 Omicron variant.

Temporary telehealth services introduced as part of COVID-19 measures will become a permanent service in our health system.

The National NAIDOC Awards are an opportunity to recognise outstanding achievements by Aboriginal and Torres Strait Islander people at the community, national and international level.

2021 is quickly coming to an end. With the holidays just around the corner, a lot of us will be travelling interstate and visiting family and friends.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Today, we released the refreshed National Aboriginal and Torres Strait Islander Health Plan 2021-2031 in partnership between the Australian Government and Aboriginal and Torres Strait Islander health leaders.

On 1 June 2021, more than 90 stakeholders from all over Australia gathered in Queenstown, Tasmania to discuss service and learning consortia for allied health.

The Australian Government has launched the National Preventive Health Strategy 2021–2030, which will provide more balance to the health system by having a stronger focus on preventive health.

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Spikevax (Moderna), also referred to as the Moderna COVID-19 vaccine, has been provisionally approved for use as a COVID-19 booster vaccine in people aged 18 years and older by the Therapeutic Goods Administration (TGA).

The COVID-19 vaccines used in Australia are critical in protecting against COVID-19 due to all variants, including the newly emerged Omicron variant.